Barham & Arceneaux v. Kozak

874 So. 2d 228, 2004 WL 444645
CourtLouisiana Court of Appeal
DecidedMarch 12, 2004
Docket2002 CA 2325
StatusPublished
Cited by28 cases

This text of 874 So. 2d 228 (Barham & Arceneaux v. Kozak) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Barham & Arceneaux v. Kozak, 874 So. 2d 228, 2004 WL 444645 (La. Ct. App. 2004).

Opinion

874 So.2d 228 (2004)

BARHAM & ARCENEAUX
v.
Charles KOZAK and Mull & Mull (a Louisiana Partnership).

No. 2002 CA 2325.

Court of Appeal of Louisiana, First Circuit.

March 12, 2004.

*231 Bruce S. Kingsdorf, Barrios, Kingsdorf & Casteix, L.L.P., New Orleans, for Plaintiff-in-Cross-Claim/Appellee Mull & Mull, A Louisiana Partnership.

Frank Tomeny, III, Jason L. Melancon, Tomeny & Fisher, Baton Rouge, for Defendant-in-Cross-Claim/Appellant Charles Kozak.

Before: PARRO, McDONALD, and CLAIBORNE,[1] JJ.

PARRO, J.

This case involves a fee dispute among multiple attorneys. An attorney appeals from a judgment dividing fees between him and a law firm on a quantum meruit basis pursuant to an oral fee-sharing agreement, and ordering him to pay 80 percent of the court costs. In its answer to the appeal, the law firm seeks modification of the trial court judgment. For the following reasons, we reverse in part, affirm in part, and render.

Factual and Procedural History

At a time when there was nationwide litigation concerning defective blood products that transmitted HIV[2] and other diseases to hemophiliacs, the Louisiana law firm of Mull & Mull (M & M) provided legal services to Gary Cross, whose son Bradley was a Louisiana hemophiliac infected with AIDS[3] from using such products. In 1993, to assist with the trial of the Cross case, M & M engaged Charles Kozak (Kozak), a sole practitioner licensed to practice law in Hawaii, who had experience in representing clients with similar claims and was familiar with the scientific principles underlying such claims. M & M agreed to share with Kozak ten percent of the attorney fees recovered in the Cross case; however, M & M did not achieve a favorable outcome and no attorney fees were recovered.[4]

Subsequently, because Kozak perceived that at that time, Louisiana's strict product liability laws created a favorable forum for such cases, Kozak associated with M & M concerning 49 HIV-positive hemophiliacs from California (Alvarez 49). On these cases, Kozak and M & M orally agreed to divide attorney fees on a 50/50 basis. Meanwhile, as M & M's involvement in AIDS-hemophiliac cases became known, it began to sign on many other non-Louisiana clients who came directly to it for representation. The contingency fee contracts with most of these clients identified M & M and Kozak as co-counsel, but did not discuss how the attorney fees would be divided between counsel. M & M and Kozak also had separate cases that were exempt from any fee-sharing between them.

In 1994, hundreds of AIDS-hemophiliac cases were consolidated into a multi-district *232 class action in the federal district court in Chicago, Illinois. Kozak and M & M represented a group of plaintiffs, including the Alvarez 49, in the Chicago proceedings. The defendants were four huge pharmaceutical companies that produced the "fractionated" products used to reduce bleeding in hemophiliacs. Kozak and Thomas Mull (Mull) of M & M also served on the plaintiffs' steering committee (PSC) until May 1997. The defendants in the Chicago proceedings eventually filed a petition seeking decertification of the litigation class, which was granted by the United States Seventh Circuit Court of Appeals in January 1996. Nonetheless, a settlement class remained in existence, and eventually a $600 million global settlement was negotiated with the defendants by the PSC. In connection with the global settlement, a $40 million attorney fee fund was created to compensate the attorneys who had represented the various plaintiffs. M & M and Kozak individually or jointly represented over 400 clients on a contingency fee basis, over 300 of whom agreed to "opt-in" to the global settlement.

Based on their desire to continue with the litigation of their cases, more than 100 of M & M's clients opted-out of the global settlement; between 70 and 90 of these were non-Louisiana residents whose claims were filed in Baton Rouge, and another 15 cases involving Louisiana residents were filed in Orleans Parish.[5] Rather than pursuing all of the opt-out clients' cases simultaneously, the plaintiffs' team agreed to focus on one of the cases in Orleans Parish to establish a model case. Kozak had no financial interest in the chosen case, but agreed to assist in the trial preparation of this matter because of its importance to the litigation or settlement of the other pending cases in which he did have a financial interest.[6] In May 1999, after months of trial, the jury in the model case returned a $35 million judgment in favor of the plaintiff; however, the trial court granted a pending exception raising the objection of prescription and dismissed the case.[7] In October 2000, the plaintiffs' team finally negotiated a settlement covering most of the opt-out cases.

Meanwhile, for the opt-in cases in Chicago, the federal district court approved the global settlement structure and attorney *233 fee fund procedure in 1997, but abrogated all contingency fee contracts. At this point, M & M and Kozak jointly hired Robert Arceneaux (Arceneaux) of Barham & Arceneaux (B & A) to pursue their fee interests in those cases. In a written agreement dated September 23, 1997, M & M and Kozak agreed to split B & A's invoiced fees and costs on a fifty/fifty basis, with litigation costs to be reimbursed monthly, but no fee payments until recovery of settlement proceeds for the opt-in clients. Their appeal and a consolidated mandamus petition concerning the contingency fees were denied by the Seventh Circuit in October 1998. Following that decision, Kozak terminated the services of B & A, who continued to represent M & M and filed a petition for certiorari with the United States Supreme Court.

The Supreme Court ultimately denied the writ application concerning the contingency fee agreements, leaving the attorney fees to be negotiated with the PSC, subject to the approval of the federal district court. B & A handled the negotiating process with the PSC on behalf of M & M, and eventually, the PSC agreed to recommend to the court that M & M and Kozak be paid a total of $2.5 million from the attorney fee fund. In May 2000, immediately preceding a fee hearing before the federal district court, M & M entered into an agreement with Kozak (the Chicago Agreement), agreeing to divide the attorney fees approved by the court on the basis of two-thirds to M & M and one-third to Kozak. M & M and Kozak further agreed that with the money each received, each would pay one-half of the fees for services rendered by B & A through the date of Kozak's termination of B & A in November 1998.[8] The court approved the $2.5 million for M & M's and Kozak's fees related to the opt-in cases.[9] Although M & M and Kozak had confirmed in open court that they had an agreement regarding the division of the fees, immediately after they left the hearing, Kozak claimed he did not understand the terms of the Chicago Agreement. Kozak insisted that Arceneaux had misled him into believing that the fee would be computed in such a way that his recovery, after payment of expenses and B & A's attorney fees, would be $912,000. Accordingly, Kozak refused to permit the PSC administrator to disburse funds for B & A's attorney fees and costs, which resulted in B & A's filing of this suit against M & M and Kozak in August 2000.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Shannon v. Vannoy
251 So. 3d 442 (Louisiana Court of Appeal, 2018)
Brown v. Terrebonne Parish Sheriff's Office
249 So. 3d 864 (Louisiana Court of Appeal, 2018)
Hataway v. AKAL Security, Inc.
235 So. 3d 1189 (Louisiana Court of Appeal, 2017)
Lori Hataway v. Akal Security, Inc.
Louisiana Court of Appeal, 2017
Davis v. Nola Home Construction, L.L.C.
222 So. 3d 833 (Louisiana Court of Appeal, 2017)
Morgan v. East Baton Rouge Parish School Board
215 So. 3d 442 (Louisiana Court of Appeal, 2017)
Schexnayder v. Bridges
190 So. 3d 764 (Louisiana Court of Appeal, 2016)
Pope v. Roberts
144 So. 3d 1059 (Louisiana Court of Appeal, 2014)
Galland v. Galland
117 So. 3d 105 (Louisiana Court of Appeal, 2013)
Grady P. Galland v. Heidi Mahl Galland
Louisiana Court of Appeal, 2013
Succession of Claby Pierre Chiasson
Louisiana Court of Appeal, 2012
Burns v. Interstate Brands Corp.
30 So. 3d 271 (Louisiana Court of Appeal, 2010)
Larry Burns v. Interstate Brands Corporation
Louisiana Court of Appeal, 2010
BAYHI v. McKey
17 So. 3d 519 (Louisiana Court of Appeal, 2009)
MJ Farms, Ltd. v. Exxon Mobil Corp.
998 So. 2d 16 (Supreme Court of Louisiana, 2008)
BARABAY PROP. HOLD. CORP. v. Boh Bros. Const. Co., LLC
991 So. 2d 74 (Louisiana Court of Appeal, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
874 So. 2d 228, 2004 WL 444645, Counsel Stack Legal Research, https://law.counselstack.com/opinion/barham-arceneaux-v-kozak-lactapp-2004.